Zevra Therapeutics Inc. (ZVRA) — Capital Reinvestment Ratio
Zevra Therapeutics Inc. (ZVRA) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow ($4.71 Million) in capital expenditures ($554.00K). Check ZVRA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zevra Therapeutics Inc. Capital Reinvestment Ratio (2021–2021)
This chart tracks Zevra Therapeutics Inc.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Zevra Therapeutics Inc. (ZVRA) cash conversion ratio.
Annual Capital Reinvestment Ratio for Zevra Therapeutics Inc. (2021–2021)
Year-by-year Capital Reinvestment Ratio for Zevra Therapeutics Inc. from 2021 to 2021. See free cash flow generation of Zevra Therapeutics Inc. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | $10.44 Million | $102.00K | — |